CD44 and breast carcinoma: Triple-negative breast cancer (TNBC) displays the breast cancer stem cell (BCSC) phenotype of CD44+/CD24-, possesses tumor-initiating properties, and is associated with stem cell-like characteristics in breast cancer (142).